Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound medicine for treating migraine headache

A migraine and drug technology, applied in the field of drugs for treating migraine, can solve the problems of poor effect, insignificant effect, poor safety, etc., and achieve the effects of obvious pharmacological effect, no addiction and low cost

Inactive Publication Date: 2010-05-12
金桂兰 +2
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Domestic scholars use traditional methods such as traditional Chinese medicine, acupuncture, and physical therapy, or a combination of Chinese and Western medicine to relieve pain, but the effect is poor, and more patients relapse
Drug therapy is also used abroad, and ergotamine, antipyretic analgesics, β-blockers, calcium ion blockers, etc. are mainly used. These drugs have defects such as poor safety and ineffective effects.
However, new preparations such as triptans are expensive and poorly accepted by patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] A compound drug for treating migraine, which is a compound drug made from the following weight ratio of various component drugs, including 300 parts of aspirin, 50 parts of caffeine, 40 parts of indomethacin, 10 parts of naphthalene, 15 parts of prednisone acetate, vitamin B 6 30 parts, 1 part of phenylthiazine.

[0025] Above-mentioned medicine is made into capsule by conventional method, takes 3 times every day, each 2 capsules. 14 days as a course of treatment

Embodiment 2

[0027] 400 parts of aspirin, 70 parts of caffeine, 50 parts of indomethacin, 30 parts of propranolol hydrochloride, 20 parts of prednisone acetate, vitamin B 6 50 parts, 2 parts of phenylthiazine.

Embodiment 3

[0029] 350 parts of aspirin, 60 parts of caffeine, 45 parts of indomethacin, 20 parts of propranolol hydrochloride, 15 parts of prednisone acetate, vitamin B 6 40 parts, 1.5 parts of phenylthiazine.

[0030] best practice

[0031] 400 parts of aspirin, 60 parts of caffeine, 40 parts of indomethacin, 20 parts of propranolol hydrochloride, 16 parts of prednisone acetate, vitamin B 6 40 parts, 1 part of phenylthiazine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A compound medicine for treating hemicrania is proportionally prepared from aspirin, caffeine, indometacin and cortal.

Description

technical field [0001] The invention relates to a medicine for treating migraine in clinical medicine, in particular to a medicine for treating migraine prepared from seven medicines as raw materials. Background technique [0002] Migraine is a common multiple disease, manifested as recurrent, pulsating severe headache on one or both sides. There are many methods for treating migraine both at home and abroad at present. Domestic scholars use traditional methods such as traditional Chinese medicine, acupuncture, and physical therapy, or a combination of Chinese and Western medicine to relieve pain in patients, but the effect is poor, and more patients relapse. Drug therapy is also used abroad, mainly using ergotamine, antipyretic analgesics, β-blockers, calcium ion blockers, etc. These drugs have defects such as poor safety and ineffective effects. However, new preparations such as triptans are expensive and poorly accepted by patients. Contents of the invention [0003]...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/616A61K31/522A61K31/405A61K31/138A61K31/573A61K31/4535A61K31/4415A61P25/06
Inventor 金桂兰奚炜邢翔飞
Owner 金桂兰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products